The interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS): clinical experience | Salugina | Modern Rheumatology Journal

Modern Rheumatology Journal
Sovremennaâ revmatologiâ

ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)

eng | рус

Preview

Modern Rheumatology Journal

Advanced search

Archives

Download this PDF file

For citations:

Salugina SO, Fedorov ES, Kuzmina NN, Zakharova EY. The interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS): clinical experience. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2014;8(4):17-24. (In Russ.) https://doi.org/10.14412/1996-7012-2014-4-17-24

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Al. M. Lila

Article Tools

Indexing metadata

How to cite item

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

Svetlana Olegovna Salugina
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

Moscow, Russia, 34A, Kashirskoe Shosse, Moscow 115522

E. S. Fedorov
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

Moscow, Russia, 34A, Kashirskoe Shosse, Moscow 115522

N. N. Kuzmina
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

Moscow, Russia, 34A, Kashirskoe Shosse, Moscow 115522

E. Yu. Zakharova
Research Center of Medical Genetics, Russian Academy of Medical Genetics
Russian Federation

Moscow, Russia, 1, Moskvorechye St., Moscow 115478

Notifications

Авторам